Patent · US Active

Anti-CD3 antibodies and methods of use

US10640572B2 · kind B2 · utility

1Cited by
33References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 29, 2017
Grant dateMay 5, 2020
Priority date—
Expiry dateNov 8, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-cluster of differentiation 3 (CD3) antibodies and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.